Kazia Therapeutics (KZIA) Shares Outstanding (2011 - 2025)

Kazia Therapeutics' Shares Outstanding (Entity) history runs 5 years deep, the most recent figure standing at $315080.7 for Q4 2022.

• Quarterly Shares Outstanding (Entity) changed N/A year-over-year to $315080.7 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $315080.7 (changed N/A YoY) and the FY2020 annual result came in at $1915.1, up 18.87% from the prior year.
• Shares Outstanding (Entity) was $315080.7 for Q4 2022 at Kazia Therapeutics, up from $3140.8 in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $315080.7 in Q4 2022 and bottomed at $1464.9 in Q2 2018.
• A 4-year average of $54167.0 and a median of $1852.2 in 2019 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2019 — Shares Outstanding (Entity) rose 9.98% — and 2020, when it surged 75.54%.
• Kazia Therapeutics' Shares Outstanding (Entity) stood at $1464.9 in 2018, then rose by 22.15% to $1789.3 in 2019, then jumped by 75.54% to $3140.8 in 2020, then surged by 9931.78% to $315080.7 in 2022.
• Business Quant data shows KZIA's Shares Outstanding (Entity) at $315080.7 in Q4 2022, $3140.8 in Q4 2020, and $1915.1 in Q2 2020.